Clinical Trials · NCT01037699
Luteinizing Hormone (LH) Supplementation in Gonadotropin-releasing Hormone (GnRH) Antagonist Cycles
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Instituto Valenciano de Infertilidad, IVI VALENCIA
- Enrollment
- 720
- Start date
- Jan 2005
- Locations
- 1 site, Spain
- Primary endpoint
- Implantation rate